Allergan Q1 Results Top View - Quick Facts

(RTTNews) - Allergan Inc. (AGN) said first-quarter net earnings attributable to the company surged to $257.3 million or $0.85 per share from $12.5 million or $0.04 per share in the prior year.

Adjusted earnings per share was $1.18, while it totaled $0.98 last year. On average, 22 analysts polled by Thomson Reuters expected earnings of $1.13 per share. Analysts' estimates typically exclude special items.

Earnings per share from continuing operations was $0.85, compared to $0.89 last year. Revenues improved to $1.646 billion from $1.460 billion in the previous year. Analysts expected revenues of $1.60 billion.

David Pyott, Allergan's Chairman of the Board and CEO, said, "In the first quarter Allergan delivered strong sales and earnings per share growth above the high end of our expectations. Furthermore, we are pleased with the continuing strength of our growing markets around the world and our market share gains in many businesses."

For the full year, the company expects adjusted earnings per share attributable to stockholders between $5.64 and $5.73, and total product net sales between $6.775 billion and $7.000 billion.

Wall Street expects earnings of $5.47 per share on revenues of $6.87 billion.